Actamax Surgical Materials


DSM and DuPont announce joint venture in surgical biomaterials.

DSM and DuPont have formed a joint venture for the development of surgical materials. The company, Actamax Surgical Material LLC, launched in February 2011. Its mission is to develop products for adhesion prevention, tissue sealing, hemostasis, and other surgical applications based on proprietary biodegradable polymer technology from DuPont.

DSM and DuPont proudly support Actamax